The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(rac)-N-{4-[(6-methyl-2,3,4,5-tetrahydro-1,5-benzothiazepin-5-yl)carbonyl]phenyl}-2-methylbenzamide ID: ALA3416767
PubChem CID: 118734334
Max Phase: Preclinical
Molecular Formula: C25H24N2O2S
Molecular Weight: 416.55
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCSc3cccc(C)c32)cc1
Standard InChI: InChI=1S/C25H24N2O2S/c1-17-7-3-4-9-21(17)24(28)26-20-13-11-19(12-14-20)25(29)27-15-6-16-30-22-10-5-8-18(2)23(22)27/h3-5,7-14H,6,15-16H2,1-2H3,(H,26,28)
Standard InChI Key: LQCRQEJXMNDRFQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
-1.4884 -1.5247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4637 6.8428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5483 5.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7442 -1.6517 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.9829 3.2321 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6064 4.0689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1195 4.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8315 -0.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2904 9.2218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9505 6.6441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5218 5.2572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1007 9.3787 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4432 11.9585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5481 12.9878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8315 0.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9404 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2507 1.3976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6326 11.7995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2069 3.0761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7805 1.6880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6062 11.4023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0348 12.7892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2039 10.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6908 10.2140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8640 7.8349 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4884 1.5247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2325 -1.4158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5141 2.7244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18 13 1 0
20 19 1 0
29 1 2 0
25 24 1 0
28 16 1 0
9 24 1 0
8 15 2 0
3 7 1 0
23 29 1 0
21 25 2 0
4 28 1 0
1 8 1 0
6 11 1 0
7 6 2 0
15 27 1 0
11 10 2 0
23 20 1 0
19 5 2 0
18 14 1 0
20 17 1 0
22 21 1 0
24 18 2 0
2 3 2 0
10 26 1 0
17 16 1 0
9 12 2 0
27 23 2 0
26 9 1 0
29 4 1 0
14 22 2 0
19 7 1 0
10 2 1 0
27 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 416.55Molecular Weight (Monoisotopic): 416.1558AlogP: 5.70#Rotatable Bonds: 3Polar Surface Area: 49.41Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 5.46CX LogD: 5.46Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.60Np Likeness Score: -1.68
References 1. Yoneda T, Tabata H, Tasaka T, Oshitari T, Takahashi H, Natsugari H.. (2015) N-benzoyl-1,5-benzothiazepine and its S-oxide as vasopressin receptor ligands: insight into the active stereochemistry around the seven-membered ring., 58 (7): [PMID:25774991 ] [10.1021/acs.jmedchem.5b00289 ] 2. Yoneda T, Tabata H, Tasaka T, Oshitari T, Takahashi H, Natsugari H.. (2015) N-benzoyl-1,5-benzothiazepine and its S-oxide as vasopressin receptor ligands: insight into the active stereochemistry around the seven-membered ring., 58 (7): [PMID:25774991 ] [10.1021/acs.jmedchem.5b00289 ] 3. Yoneda T, Tabata H, Tasaka T, Oshitari T, Takahashi H, Natsugari H.. (2015) N-benzoyl-1,5-benzothiazepine and its S-oxide as vasopressin receptor ligands: insight into the active stereochemistry around the seven-membered ring., 58 (7): [PMID:25774991 ] [10.1021/acs.jmedchem.5b00289 ] 4. Glunz PW.. (2018) Recent encounters with atropisomerism in drug discovery., 28 (2.0): [PMID:29223590 ] [10.1016/j.bmcl.2017.11.050 ]